Unlike p53, p27 failed to exhibit an anti-tumor genetic interaction with Ku80

Valerie B Holcomb1, Hannes Vogel, Paul Hasty

  • 1The University of Texas Health Science Center at San Antonio, The Institute of Biotechnology, The Department of Molecular Medicine, San Antonio, TX 78245-3207, USA.

Insights

Ku80 maintains genome integrity by repairing DNA double-strand breaks. Ku80 deletion did not worsen cancer with p27 deletion, suggesting p27 does not genetically interact with Ku80 to suppress tumors.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Ku80 is crucial for DNA double-strand break repair via nonhomologous end joining (NHEJ).
  • Ku80-deficient cells exhibit genomic instability but paradoxically low cancer rates, potentially due to enhanced p53-mediated DNA damage responses and senescence.
  • p27 mutant mice show increased pituitary adenomas, exacerbated by DNA damage.

Purpose of the Study:

  • To investigate a potential anti-tumor genetic interaction between Ku80 and p27(Kip1) (p27).
  • To determine if combined deletion of Ku80 and p27 exacerbates oncogenesis compared to single mutations.

Main Methods:

  • Comparative analysis of cancer incidence in single Ku80-mutant and double Ku80/p27-mutant mice.
  • Assessment of cellular senescence in fibroblasts from these mutant mice.

Main Results:

  • Combined deletion of Ku80 and p27 did not increase cancer incidence compared to single mutants.
  • Ku80/p27-double mutant fibroblasts displayed premature cellular senescence, similar to Ku80-mutant fibroblasts.
  • p27 did not show a significant genetic interaction with Ku80 in tumor suppression.

Conclusions:

  • The cyclin-dependent kinase inhibitor p27 does not appear to genetically interact with Ku80 to suppress tumor formation.
  • DNA damage responses triggered by gamma-radiation may differ mechanistically from those resulting from Ku80 deletion, impacting oncogenesis differently.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...